(S (NP (NP (JJ Purpose-Optimal) (NN use)) (PP (IN of) (NP (NP (ADJP (VBN established) (CC and) (VBG imaging)) (NNS methods)) (, ,) (PP (JJ such) (IN as) (NP (NP (JJ multiparametric) (JJ magnetic) (NN resonance) (NN imaging)) (PRN (-LRB- -LRB-) (NP (NN mpMRI)) (-RRB- -RRB-))))))) (VP (MD can) (VP (VP (ADVP (RB simultaneously)) (VB identify) (NP (JJ key) (JJ functional) (NNS parameters))) (CC and) (VP (VB provide) (NP (NP (JJ unique) (VBG imaging) (NNS phenotypes)) (PP (IN of) (NP (NN breast) (NN cancer))))))) (. .))
(S (ADVP (RB Therefore)) (, ,) (NP (PRP we)) (VP (VBP have) (VP (VBN developed) (CC and) (VBN implemented) (NP (NP (DT a) (JJ new) (JJ machine-learning) (JJ informatic) (NN system)) (SBAR (WHNP (WDT that)) (S (VP (VBZ integrates) (NP (NP (JJ clinical) (NNS variables)) (, ,) (VP (VBN derived) (PP (IN from) (NP (VBG imaging) (CC and) (JJ clinical) (NN health) (NNS records)))) (, ,)) (SBAR (S (VP (TO to) (VP (VB compare) (PP (IN with) (NP (NP (DT the) (JJ 21-gene) (NN array) (NN assay)) (, ,) (NP (NNP OncotypeDX)))))))))))))) (. .))
(S (FRAG (S (NNS Materials) (CC and))) (NP (NN methods-We)) (VP (VBD tested) (NP (PRP$ our) (NNS informatics) (VBG modeling)) (PP (IN in) (NP (NP (DT a) (NN subset)) (PP (IN of) (NP (NP (NNS patients)) (PRN (-LRB- -LRB-) (NP (JJ n=81)) (-RRB- -RRB-)) (SBAR (WHNP (WP who)) (S (VP (VP (VBD had) (NP (NNP ER+) (NN disease))) (CC and) (VP (JJ underwent) (NP (NNP OncotypeDX) (NN gene) (NN expression) (CC and) (NN breast) (NN mpMRI) (NN testing))))))))))) (. .))
(S (NP (DT The) (JJ machine-learning) (JJ informatic) (NN method)) (VP (VBZ is) (VP (VBN termed) (S (NP (JJ Integrated) (NNP Radiomic) (NNP Informatic) (NNP System-IRIS))) (VP (VBD was) (VP (VBN applied) (PP (TO to) (NP (NP (NP (DT the) (NN mpMRI)) (, ,) (NP (ADJP (JJ clinical) (CC and) (JJ pathologic)) (NNS descriptors))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (DT a) (NN gene) (NN array) (NN analysis)))))))) (. .))
(NP (NP (DT The) (NNP IRIS) (NN method)) (VP (VBG using) (NP (NP (DT an) (JJ advanced) (NN graph) (JJ theoretic) (NN model)) (CC and) (NP (JJ quantitative) (NNS metrics)))) (. .))
(S (NP (NP (JJ Summary) (NNS statistics)) (PRN (-LRB- -LRB-) (NP (NN mean) (CC and) (JJ standard) (NNS deviations)) (-RRB- -RRB-)) (PP (IN for) (NP (DT the) (JJ quantitative) (NN imaging) (NNS parameters)))) (VP (VBD were) (VP (VBN obtained))) (. .))
(S (NP (NP (NN Sensitivity) (CC and) (NN specificity)) (CC and) (NP (NP (NNP Area)) (PP (IN Under) (NP (DT the) (NNP Curve))))) (VP (VBD were) (VP (VBN calculated) (PP (IN for) (NP (NP (DT the) (NN classification)) (PP (IN of) (NP (DT the) (NNS patients))))))) (. .))
(S (NP (NP (JJ Results-The) (NNP OncotypeDX) (NN classification)) (PP (IN by) (NP (NNP IRIS) (NN model)))) (VP (VBD had) (NP (NP (NP (NN sensitivity)) (PP (IN of) (NP (CD 95) (NN %)))) (CC and) (NP (NP (NN specificity)) (PP (IN of) (NP (CD 89) (NN %))))) (PP (IN with) (NP (NP (NNP AUC)) (PP (IN of) (NP (CD 0.92)))))) (. .))
(S (NP (DT The) (NN breast) (NN lesion) (NN size)) (VP (VP (VBD was) (ADJP (JJR larger)) (PP (IN for) (NP (DT the) (JJ high-risk) (NNS groups)))) (CC and) (VP (ADJP (JJR lower)) (PP (IN for) (NP (DT both) (NP (JJ low) (NN risk)) (CC and) (JJ intermediate) (NN risk) (NNS groups))))) (. .))
(S (NP (EX There)) (VP (VBD were) (NP (NP (JJ significant) (NNS differences)) (PP (IN in) (NP (NNP PK-DCE) (CC and) (NNP ADC) (NN map) (NNS values)))) (PP (IN in) (NP (DT each) (NN group)))) (. .))
(S (NP (NP (DT The) (NNP ADC) (NN map) (NNS values)) (PP (IN for) (NP (JJ high-) (CC and) (JJ intermediate-risk) (NNS groups)))) (VP (VBD were) (ADJP (ADJP (RB significantly) (JJR lower)) (PP (IN than) (NP (DT the) (JJ low-risk) (NN group))))) (. .))
(S (NP (JJ Conclusion-These) (JJ initial) (NNS studies)) (VP (VBP provide) (NP (NP (JJR deeper) (NNS understandings)) (PP (IN of) (NP (NP (VBG imaging) (NNS features)) (CC and) (NP (JJ molecular) (NN gene) (NN array) (NNP OncotypeDX) (NN score)))))) (. .))
(S (NP (DT This) (NN insight)) (VP (VBZ provides) (NP (NP (DT the) (NN foundation)) (SBAR (S (VP (TO to) (VP (VB relate) (NP (DT these) (VBG imaging) (NNS features)) (PP (TO to) (NP (NP (DT the) (NN assessment)) (PP (IN of) (NP (NN treatment) (NN response))) (PP (IN for) (NP (JJ improved) (JJ personalized) (NN medicine))))))))))) (. .))
